Neuroblastoma Susceptibility To 7 C4225207
Genetic predisposition to developing neuroblastoma, a nerve cell cancer that occurs mainly in children. Treatment depends on cancer staging and may involve multiple approaches.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe headache
Abdominal mass
(oncologic)Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Bone pain
(oncologic)Hypertension
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Enhanced Screening Protocol
Intensive screening program for early tumor detection in individuals with susceptibility variants. Protocol development considers specific genetic modifiers associated with C4225207.
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Definitive Surgical Excision
Primary tumor resection performed by experienced surgical oncology teams. Complete resection remains the cornerstone of management when tumors are identified and resectable.
Additional treatment options
Targeted Biological Therapy
Emerging biological agents targeting specific molecular pathways implicated in neuroblastoma pathogenesis. Treatment selection guided by tumor molecular profiling.
medicationFamily Screening and Cascade Testing
Systematic evaluation of at-risk family members to identify additional carriers and establish appropriate surveillance protocols across generations.
lifestylePsycho-oncology Support
Specialized psychological support addressing anxiety related to ongoing surveillance, treatment decisions, and family impact of genetic susceptibility.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Neuroblastoma Susceptibility To 7 C4225207?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Neuroblastoma Susceptibility To 7 C4225207. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy